POLR2A and neoplasm: These nanoparticles accumulated in both POLR2Aneutral and POLR2Aloss tumors, but inhibition of POLR2A significantly reduced tumor growth in heterozygous POLR2Aloss tumors, still avoiding systemic side effects (Xu et al., 2019).